Research ArticleArticle
Continual Maintenance of Remission Defined by the ACR/EULAR Criteria in Daily Practice Leads to Better Functional Outcomes in Patients with Rheumatoid Arthritis
Kumi Shidara, Ayako Nakajima, Eisuke Inoue, Daisuke Hoshi, Naoki Sugimoto, Yohei Seto, Eiichi Tanaka, Shigeki Momohara, Atsuo Taniguchi and Hisashi Yamanaka
The Journal of Rheumatology December 2016, jrheum.160395; DOI: https://doi.org/10.3899/jrheum.160395
Kumi Shidara
From the Institute of Rheumatology, Tokyo Women’s Medical University, Tokyo, Japan. H. Yamanaka has received research grants from Astellas Pharma Inc. and Bristol-Myers-Squibb. K.S. Shidara, MD, PhD, Instructor, Institute of Rheumatology, Tokyo Women’s Medical University; A.N. Nakajima, MD, PhD, Associate Professor, Institute of Rheumatology, Tokyo Women’s Medical University; E.I. Inoue, PhD, Institute of Rheumatology, Tokyo Women’s Medical University; D.H. Hoshi, MD, Instructor, Institute of Rheumatology, Tokyo Women’s Medical University; N.S. Sugimoto, MD, Instructor, Institute of Rheumatology, Tokyo Women’s Medical University; Y.S. Seto, MD, PhD, Assistant Professor, Institute of Rheumatology, Tokyo Women’s Medical University; E.T. Tanaka, MD, PhD, Assistant Professor, Institute of Rheumatology, Tokyo Women’s Medical University; S.M. Momohara, MD, PhD, Professor, Institute of Rheumatology, Tokyo Women’s Medical University; A.T. Taniguchi, MD, PhD, Professor, Institute of Rheumatology, Tokyo Women’s Medical University; H.Y. Yamanaka, MD, PhD, Professor, Institute of Rheumatology, Tokyo Women’s Medical University. Address correspondence to Dr. A. Nakajima, Institute of Rheumatology, Tokyo Women’s Medical University, 10-22 Kawada-cho, Shinjuku-ku, Tokyo, Japan. E-mail: ayakonkj@twmu.ac.jp. Accepted for publication October 25, 2016.
Ayako Nakajima
From the Institute of Rheumatology, Tokyo Women’s Medical University, Tokyo, Japan. H. Yamanaka has received research grants from Astellas Pharma Inc. and Bristol-Myers-Squibb. K.S. Shidara, MD, PhD, Instructor, Institute of Rheumatology, Tokyo Women’s Medical University; A.N. Nakajima, MD, PhD, Associate Professor, Institute of Rheumatology, Tokyo Women’s Medical University; E.I. Inoue, PhD, Institute of Rheumatology, Tokyo Women’s Medical University; D.H. Hoshi, MD, Instructor, Institute of Rheumatology, Tokyo Women’s Medical University; N.S. Sugimoto, MD, Instructor, Institute of Rheumatology, Tokyo Women’s Medical University; Y.S. Seto, MD, PhD, Assistant Professor, Institute of Rheumatology, Tokyo Women’s Medical University; E.T. Tanaka, MD, PhD, Assistant Professor, Institute of Rheumatology, Tokyo Women’s Medical University; S.M. Momohara, MD, PhD, Professor, Institute of Rheumatology, Tokyo Women’s Medical University; A.T. Taniguchi, MD, PhD, Professor, Institute of Rheumatology, Tokyo Women’s Medical University; H.Y. Yamanaka, MD, PhD, Professor, Institute of Rheumatology, Tokyo Women’s Medical University. Address correspondence to Dr. A. Nakajima, Institute of Rheumatology, Tokyo Women’s Medical University, 10-22 Kawada-cho, Shinjuku-ku, Tokyo, Japan. E-mail: ayakonkj@twmu.ac.jp. Accepted for publication October 25, 2016.
Eisuke Inoue
From the Institute of Rheumatology, Tokyo Women’s Medical University, Tokyo, Japan. H. Yamanaka has received research grants from Astellas Pharma Inc. and Bristol-Myers-Squibb. K.S. Shidara, MD, PhD, Instructor, Institute of Rheumatology, Tokyo Women’s Medical University; A.N. Nakajima, MD, PhD, Associate Professor, Institute of Rheumatology, Tokyo Women’s Medical University; E.I. Inoue, PhD, Institute of Rheumatology, Tokyo Women’s Medical University; D.H. Hoshi, MD, Instructor, Institute of Rheumatology, Tokyo Women’s Medical University; N.S. Sugimoto, MD, Instructor, Institute of Rheumatology, Tokyo Women’s Medical University; Y.S. Seto, MD, PhD, Assistant Professor, Institute of Rheumatology, Tokyo Women’s Medical University; E.T. Tanaka, MD, PhD, Assistant Professor, Institute of Rheumatology, Tokyo Women’s Medical University; S.M. Momohara, MD, PhD, Professor, Institute of Rheumatology, Tokyo Women’s Medical University; A.T. Taniguchi, MD, PhD, Professor, Institute of Rheumatology, Tokyo Women’s Medical University; H.Y. Yamanaka, MD, PhD, Professor, Institute of Rheumatology, Tokyo Women’s Medical University. Address correspondence to Dr. A. Nakajima, Institute of Rheumatology, Tokyo Women’s Medical University, 10-22 Kawada-cho, Shinjuku-ku, Tokyo, Japan. E-mail: ayakonkj@twmu.ac.jp. Accepted for publication October 25, 2016.
Daisuke Hoshi
From the Institute of Rheumatology, Tokyo Women’s Medical University, Tokyo, Japan. H. Yamanaka has received research grants from Astellas Pharma Inc. and Bristol-Myers-Squibb. K.S. Shidara, MD, PhD, Instructor, Institute of Rheumatology, Tokyo Women’s Medical University; A.N. Nakajima, MD, PhD, Associate Professor, Institute of Rheumatology, Tokyo Women’s Medical University; E.I. Inoue, PhD, Institute of Rheumatology, Tokyo Women’s Medical University; D.H. Hoshi, MD, Instructor, Institute of Rheumatology, Tokyo Women’s Medical University; N.S. Sugimoto, MD, Instructor, Institute of Rheumatology, Tokyo Women’s Medical University; Y.S. Seto, MD, PhD, Assistant Professor, Institute of Rheumatology, Tokyo Women’s Medical University; E.T. Tanaka, MD, PhD, Assistant Professor, Institute of Rheumatology, Tokyo Women’s Medical University; S.M. Momohara, MD, PhD, Professor, Institute of Rheumatology, Tokyo Women’s Medical University; A.T. Taniguchi, MD, PhD, Professor, Institute of Rheumatology, Tokyo Women’s Medical University; H.Y. Yamanaka, MD, PhD, Professor, Institute of Rheumatology, Tokyo Women’s Medical University. Address correspondence to Dr. A. Nakajima, Institute of Rheumatology, Tokyo Women’s Medical University, 10-22 Kawada-cho, Shinjuku-ku, Tokyo, Japan. E-mail: ayakonkj@twmu.ac.jp. Accepted for publication October 25, 2016.
Naoki Sugimoto
From the Institute of Rheumatology, Tokyo Women’s Medical University, Tokyo, Japan. H. Yamanaka has received research grants from Astellas Pharma Inc. and Bristol-Myers-Squibb. K.S. Shidara, MD, PhD, Instructor, Institute of Rheumatology, Tokyo Women’s Medical University; A.N. Nakajima, MD, PhD, Associate Professor, Institute of Rheumatology, Tokyo Women’s Medical University; E.I. Inoue, PhD, Institute of Rheumatology, Tokyo Women’s Medical University; D.H. Hoshi, MD, Instructor, Institute of Rheumatology, Tokyo Women’s Medical University; N.S. Sugimoto, MD, Instructor, Institute of Rheumatology, Tokyo Women’s Medical University; Y.S. Seto, MD, PhD, Assistant Professor, Institute of Rheumatology, Tokyo Women’s Medical University; E.T. Tanaka, MD, PhD, Assistant Professor, Institute of Rheumatology, Tokyo Women’s Medical University; S.M. Momohara, MD, PhD, Professor, Institute of Rheumatology, Tokyo Women’s Medical University; A.T. Taniguchi, MD, PhD, Professor, Institute of Rheumatology, Tokyo Women’s Medical University; H.Y. Yamanaka, MD, PhD, Professor, Institute of Rheumatology, Tokyo Women’s Medical University. Address correspondence to Dr. A. Nakajima, Institute of Rheumatology, Tokyo Women’s Medical University, 10-22 Kawada-cho, Shinjuku-ku, Tokyo, Japan. E-mail: ayakonkj@twmu.ac.jp. Accepted for publication October 25, 2016.
Yohei Seto
From the Institute of Rheumatology, Tokyo Women’s Medical University, Tokyo, Japan. H. Yamanaka has received research grants from Astellas Pharma Inc. and Bristol-Myers-Squibb. K.S. Shidara, MD, PhD, Instructor, Institute of Rheumatology, Tokyo Women’s Medical University; A.N. Nakajima, MD, PhD, Associate Professor, Institute of Rheumatology, Tokyo Women’s Medical University; E.I. Inoue, PhD, Institute of Rheumatology, Tokyo Women’s Medical University; D.H. Hoshi, MD, Instructor, Institute of Rheumatology, Tokyo Women’s Medical University; N.S. Sugimoto, MD, Instructor, Institute of Rheumatology, Tokyo Women’s Medical University; Y.S. Seto, MD, PhD, Assistant Professor, Institute of Rheumatology, Tokyo Women’s Medical University; E.T. Tanaka, MD, PhD, Assistant Professor, Institute of Rheumatology, Tokyo Women’s Medical University; S.M. Momohara, MD, PhD, Professor, Institute of Rheumatology, Tokyo Women’s Medical University; A.T. Taniguchi, MD, PhD, Professor, Institute of Rheumatology, Tokyo Women’s Medical University; H.Y. Yamanaka, MD, PhD, Professor, Institute of Rheumatology, Tokyo Women’s Medical University. Address correspondence to Dr. A. Nakajima, Institute of Rheumatology, Tokyo Women’s Medical University, 10-22 Kawada-cho, Shinjuku-ku, Tokyo, Japan. E-mail: ayakonkj@twmu.ac.jp. Accepted for publication October 25, 2016.
Eiichi Tanaka
From the Institute of Rheumatology, Tokyo Women’s Medical University, Tokyo, Japan. H. Yamanaka has received research grants from Astellas Pharma Inc. and Bristol-Myers-Squibb. K.S. Shidara, MD, PhD, Instructor, Institute of Rheumatology, Tokyo Women’s Medical University; A.N. Nakajima, MD, PhD, Associate Professor, Institute of Rheumatology, Tokyo Women’s Medical University; E.I. Inoue, PhD, Institute of Rheumatology, Tokyo Women’s Medical University; D.H. Hoshi, MD, Instructor, Institute of Rheumatology, Tokyo Women’s Medical University; N.S. Sugimoto, MD, Instructor, Institute of Rheumatology, Tokyo Women’s Medical University; Y.S. Seto, MD, PhD, Assistant Professor, Institute of Rheumatology, Tokyo Women’s Medical University; E.T. Tanaka, MD, PhD, Assistant Professor, Institute of Rheumatology, Tokyo Women’s Medical University; S.M. Momohara, MD, PhD, Professor, Institute of Rheumatology, Tokyo Women’s Medical University; A.T. Taniguchi, MD, PhD, Professor, Institute of Rheumatology, Tokyo Women’s Medical University; H.Y. Yamanaka, MD, PhD, Professor, Institute of Rheumatology, Tokyo Women’s Medical University. Address correspondence to Dr. A. Nakajima, Institute of Rheumatology, Tokyo Women’s Medical University, 10-22 Kawada-cho, Shinjuku-ku, Tokyo, Japan. E-mail: ayakonkj@twmu.ac.jp. Accepted for publication October 25, 2016.
Shigeki Momohara
From the Institute of Rheumatology, Tokyo Women’s Medical University, Tokyo, Japan. H. Yamanaka has received research grants from Astellas Pharma Inc. and Bristol-Myers-Squibb. K.S. Shidara, MD, PhD, Instructor, Institute of Rheumatology, Tokyo Women’s Medical University; A.N. Nakajima, MD, PhD, Associate Professor, Institute of Rheumatology, Tokyo Women’s Medical University; E.I. Inoue, PhD, Institute of Rheumatology, Tokyo Women’s Medical University; D.H. Hoshi, MD, Instructor, Institute of Rheumatology, Tokyo Women’s Medical University; N.S. Sugimoto, MD, Instructor, Institute of Rheumatology, Tokyo Women’s Medical University; Y.S. Seto, MD, PhD, Assistant Professor, Institute of Rheumatology, Tokyo Women’s Medical University; E.T. Tanaka, MD, PhD, Assistant Professor, Institute of Rheumatology, Tokyo Women’s Medical University; S.M. Momohara, MD, PhD, Professor, Institute of Rheumatology, Tokyo Women’s Medical University; A.T. Taniguchi, MD, PhD, Professor, Institute of Rheumatology, Tokyo Women’s Medical University; H.Y. Yamanaka, MD, PhD, Professor, Institute of Rheumatology, Tokyo Women’s Medical University. Address correspondence to Dr. A. Nakajima, Institute of Rheumatology, Tokyo Women’s Medical University, 10-22 Kawada-cho, Shinjuku-ku, Tokyo, Japan. E-mail: ayakonkj@twmu.ac.jp. Accepted for publication October 25, 2016.
Atsuo Taniguchi
From the Institute of Rheumatology, Tokyo Women’s Medical University, Tokyo, Japan. H. Yamanaka has received research grants from Astellas Pharma Inc. and Bristol-Myers-Squibb. K.S. Shidara, MD, PhD, Instructor, Institute of Rheumatology, Tokyo Women’s Medical University; A.N. Nakajima, MD, PhD, Associate Professor, Institute of Rheumatology, Tokyo Women’s Medical University; E.I. Inoue, PhD, Institute of Rheumatology, Tokyo Women’s Medical University; D.H. Hoshi, MD, Instructor, Institute of Rheumatology, Tokyo Women’s Medical University; N.S. Sugimoto, MD, Instructor, Institute of Rheumatology, Tokyo Women’s Medical University; Y.S. Seto, MD, PhD, Assistant Professor, Institute of Rheumatology, Tokyo Women’s Medical University; E.T. Tanaka, MD, PhD, Assistant Professor, Institute of Rheumatology, Tokyo Women’s Medical University; S.M. Momohara, MD, PhD, Professor, Institute of Rheumatology, Tokyo Women’s Medical University; A.T. Taniguchi, MD, PhD, Professor, Institute of Rheumatology, Tokyo Women’s Medical University; H.Y. Yamanaka, MD, PhD, Professor, Institute of Rheumatology, Tokyo Women’s Medical University. Address correspondence to Dr. A. Nakajima, Institute of Rheumatology, Tokyo Women’s Medical University, 10-22 Kawada-cho, Shinjuku-ku, Tokyo, Japan. E-mail: ayakonkj@twmu.ac.jp. Accepted for publication October 25, 2016.
Hisashi Yamanaka
From the Institute of Rheumatology, Tokyo Women’s Medical University, Tokyo, Japan. H. Yamanaka has received research grants from Astellas Pharma Inc. and Bristol-Myers-Squibb. K.S. Shidara, MD, PhD, Instructor, Institute of Rheumatology, Tokyo Women’s Medical University; A.N. Nakajima, MD, PhD, Associate Professor, Institute of Rheumatology, Tokyo Women’s Medical University; E.I. Inoue, PhD, Institute of Rheumatology, Tokyo Women’s Medical University; D.H. Hoshi, MD, Instructor, Institute of Rheumatology, Tokyo Women’s Medical University; N.S. Sugimoto, MD, Instructor, Institute of Rheumatology, Tokyo Women’s Medical University; Y.S. Seto, MD, PhD, Assistant Professor, Institute of Rheumatology, Tokyo Women’s Medical University; E.T. Tanaka, MD, PhD, Assistant Professor, Institute of Rheumatology, Tokyo Women’s Medical University; S.M. Momohara, MD, PhD, Professor, Institute of Rheumatology, Tokyo Women’s Medical University; A.T. Taniguchi, MD, PhD, Professor, Institute of Rheumatology, Tokyo Women’s Medical University; H.Y. Yamanaka, MD, PhD, Professor, Institute of Rheumatology, Tokyo Women’s Medical University. Address correspondence to Dr. A. Nakajima, Institute of Rheumatology, Tokyo Women’s Medical University, 10-22 Kawada-cho, Shinjuku-ku, Tokyo, Japan. E-mail: ayakonkj@twmu.ac.jp. Accepted for publication October 25, 2016.
Published eLetters
eLetters are comments published online only and are not peer-reviewed. Publication of eLetter submissions is not guaranteed, and all submissions are reviewed and edited at the discretion of The Journal's staff.
If you wish to publish Letters to the Editor or Correspondence, please submit through our online submission system ScholarOne Manuscripts.
Jump to comment:
No eLetters have been published for this article.
In this issue
The Journal of Rheumatology
Vol. 51, Issue 4
1 Apr 2024
Continual Maintenance of Remission Defined by the ACR/EULAR Criteria in Daily Practice Leads to Better Functional Outcomes in Patients with Rheumatoid Arthritis
Kumi Shidara, Ayako Nakajima, Eisuke Inoue, Daisuke Hoshi, Naoki Sugimoto, Yohei Seto, Eiichi Tanaka, Shigeki Momohara, Atsuo Taniguchi, Hisashi Yamanaka
The Journal of Rheumatology Dec 2016, jrheum.160395; DOI: 10.3899/jrheum.160395
Continual Maintenance of Remission Defined by the ACR/EULAR Criteria in Daily Practice Leads to Better Functional Outcomes in Patients with Rheumatoid Arthritis
Kumi Shidara, Ayako Nakajima, Eisuke Inoue, Daisuke Hoshi, Naoki Sugimoto, Yohei Seto, Eiichi Tanaka, Shigeki Momohara, Atsuo Taniguchi, Hisashi Yamanaka
The Journal of Rheumatology Dec 2016, jrheum.160395; DOI: 10.3899/jrheum.160395